Rheumatoid arthritis pharmacogenomics

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.11, Iss.5, 2010-05, pp. : 617-619

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pharmacogenomics of tumor necrosis factor antagonists in rheumatoid arthritis

By Ranganathan Prabha

Pharmacogenomics, Vol. 6, Iss. 5, 2005-07 ,pp. : 481-490

Future Medicine

Access to resources Recommend Favorite

Research Highlights: Highlights from the latest research in rheumatoid arthritis pharmacogenomics

By Pawlik Andrzej Drozdzik Marek

Pharmacogenomics, Vol. 14, Iss. 8, 2013-06 ,pp. : 857-860

Future Medicine

Access to resources Recommend Favorite

Meloxicam in rheumatoid arthritis

By Ahmed Mansoor Khanna Dinesh Furst Daniel E

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 4, 2005-12 ,pp. : 739-751

Informa Healthcare

Access to resources Recommend Favorite

Targeted therapy in rheumatoid arthritis

By Kller Marcus D

Expert Opinion on Drug Discovery, Vol. 3, Iss. 3, 2008-03 ,pp. : 329-342

Informa Healthcare

Access to resources Recommend Favorite

Food sensitivity and rheumatoid arthritis

By Gamlin L. Brostoff J.

Environmental Toxicology and Pharmacology, Vol. 4, Iss. 1, 1997-11 ,pp. : 43-49

Elsevier

Access to resources Recommend Favorite